AUTONOMIX MEDICAL, INC. Earnings Per Share (Basic)
AUTONOMIX MEDICAL, INC. (AMIX) reported Earnings Per Share (Basic) of -$5.02 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- AUTONOMIX MEDICAL, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$5.02.
- AUTONOMIX MEDICAL, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.23.
- AUTONOMIX MEDICAL, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.36.
- AUTONOMIX MEDICAL, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$1.38.
- AUTONOMIX MEDICAL, INC. earnings per share, basic for fiscal 2026 was -$2.32.
- AUTONOMIX MEDICAL, INC. earnings per share, basic for fiscal 2025 was -$6.46.
- AUTONOMIX MEDICAL, INC. earnings per share, basic for fiscal 2024 was -$14.82.
- AUTONOMIX MEDICAL, INC. earnings per share, basic for fiscal 2023 was -$0.17.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.02 10-Q · filed 2026-08-13 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.45 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-05-27 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-05-27 | -$1.56 derived: net income ÷ weighted average shares · filed 2026-05-27 | -$2.32 10-K · filed 2026-05-27 | ||||
| 2025-12-31 | -$0.36 10-Q · filed 2026-02-11 | -$1.49 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$2.41 10-Q · filed 2026-02-11 | -$5.90 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-09-30 | -$1.38 10-Q · filed 2025-11-12 | -$2.53 10-Q · filed 2025-11-12 | -$8.01 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$9.80 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | -$22.69 10-Q · filed 2026-08-13 | -$1.07 10-Q · filed 2025-08-13 | -$10.17 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$11.03 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$13.54 derived: net income ÷ weighted average shares · filed 2026-08-13 | |||
| 2025-03-31 | -$4.15 derived: net income ÷ weighted average shares · filed 2026-05-27 | -$6.14 derived: net income ÷ weighted average shares · filed 2026-05-27 | -$8.70 derived: net income ÷ weighted average shares · filed 2026-05-27 | -$6.46 10-K · filed 2026-05-27 | ||||
| 2024-12-31 | -$1.46 10-Q · filed 2026-02-11 | -$3.58 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$5.72 10-Q · filed 2026-02-11 | -$17.27 derived: net income ÷ weighted average shares · filed 2026-02-11 | ||||
| 2024-09-30 | -$2.27 10-Q · filed 2025-11-12 | -$2.47 10-Q · filed 2024-11-08 | -$4.48 10-Q · filed 2025-11-12 | -$5.28 10-Q · filed 2024-11-08 | -$17.33 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$20.74 derived: net income ÷ weighted average shares · filed 2026-02-11 | ||
| 2024-06-30 | -$2.20 10-Q · filed 2025-08-13 | -$0.14 10-Q · filed 2024-08-13 | -$15.18 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$18.72 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$26.67 derived: net income ÷ weighted average shares · filed 2026-02-11 | |||
| 2024-03-31 | -$13.26 derived: net income ÷ weighted average shares · filed 2025-05-29 | -$17.03 derived: net income ÷ weighted average shares · filed 2025-05-29 | -$25.74 derived: net income ÷ weighted average shares · filed 2025-05-29 | -$14.82 10-K · filed 2025-05-29 | -$1.05 10-K · filed 2024-05-31 | |||
| 2023-12-31 | -$3.07 10-Q · filed 2025-02-13 | -$0.23 10-Q · filed 2024-02-13 | -$10.76 derived: net income ÷ weighted average shares · filed 2025-02-13 | -$10.02 10-Q · filed 2025-02-13 | -$0.74 10-Q · filed 2024-02-13 | -$1.60 derived: net income ÷ weighted average shares · filed 2025-02-13 | ||
| 2023-09-30 | -$8.78 10-Q · filed 2024-11-08 | -$10.36 10-Q · filed 2024-11-08 | -$0.88 derived: net income ÷ weighted average shares · filed 2025-02-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2025-02-13 | ||||
| 2023-06-30 | -$0.07 10-Q · filed 2024-08-13 | -$0.12 derived: net income ÷ weighted average shares · filed 2025-02-13 | -$0.17 derived: net income ÷ weighted average shares · filed 2025-02-13 | |||||
| 2023-03-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2024-05-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2024-05-31 | -$0.17 10-K · filed 2024-05-31 | |||||
| 2022-12-31 | -$0.05 10-Q · filed 2024-02-13 | -$0.11 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |